Ray Dalio Treace Medical Concepts, Inc. Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 36,698 shares of TMCI stock, worth $215,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,698
Previous 33,520
9.48%
Holding current value
$215,784
Previous $427,000
11.94%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TMCI
# of Institutions
131Shares Held
40.7MCall Options Held
185KPut Options Held
37.1K-
Vanguard Group Inc Valley Forge, PA4.3MShares$25.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.7MShares$21.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$19.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.4MShares$14.1 Million0.43% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.33MShares$13.7 Million0.08% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $326M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...